NCT00599248View on ClinicalTrials.gov

Safety Study of TissueGene-C in Degenerative Joint Disease of the Knee

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2010

Conditions
Osteoarthritis, Knee
Interventions
BIOLOGICAL

TissueGene-C

TissueGene-C at 3x10e6, 1x10e7 or 3x10e7 cells/joint to be administered by intra-articular injection

BIOLOGICAL

Placebo

Placebo control (DMEM)

Trial Locations (2)

21215

Sinai Hospital of Baltimore, Baltimore

22205

Commonwealth Orthopedics, Arlington

Sponsors
All Listed Sponsors
lead

Kolon TissueGene, Inc.

INDUSTRY